Jeffrey K Kachmann, MD | |
7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 | |
(260) 436-2416 | |
(260) 436-6936 |
Full Name | Jeffrey K Kachmann |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7956 W Jefferson Blvd, Fort Wayne, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659378123 | NPI | - | NPPES |
140004182 | Other | IN | RR MEDICARE |
4657111 | Medicaid | MI | |
0278739 | Medicaid | OH | |
200085300 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 01045166A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeffrey K Kachmann, MD 7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 436-2416 | Jeffrey K Kachmann, MD 7956 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 436-2416 |
News Archive
Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal disease and death, according to a study in the June 15 issue of JAMA.
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced today that the US FDA has granted orphan drug designation for QPI-1002 (also referred to as "I5NP"), a synthetic siRNA targeting p53 mRNA for the prophylaxis of delayed graft function (DGF) in kidney transplant patients.
Adhesions – bands of scar tissue that bind together two internal body surfaces – develop in 55 percent to more than 90 percent of patients undergoing surgery, depending on the type of operation. They are part of normal healing, but when surfaces fuse together that shouldn't, serious pain and complications can result.
Self-disorders – also known as anomalous self-experiences – are highly specific to individuals with schizophrenia-spectrum disorders, Danish research indicates.
› Verified 6 days ago
Rudy A. Kachmann, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7900 W Jefferson Blvd Ste 201, Fort Wayne, IN 46804 Phone: 260-432-2297 Fax: 260-434-6420 | |
Tyler Atkins, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-425-6780 | |
Dr. Stephanie R Falatko, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-425-6780 Fax: 260-425-6615 | |
Larry Van Carson, M.D., MBA Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-425-6780 Fax: 260-425-6615 | |
Dr. Jason M Voorhies, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-425-6780 Fax: 260-425-6615 | |
Guangbin Xia, MD, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr Ste 110, Fort Wayne, IN 46845 Phone: 260-425-6780 Fax: 260-458-6789 |